The Immunological Role of Interleukin-10 in Chronic Renal Disease Patients of Thi-Qar Province
DOI:
https://doi.org/10.32792/utq/utjsci/v11i2.1266Keywords:
Keywords: IL-10, Anti-Inflammation, CRF, DMAbstract
Chronic renal disease (CRD) is a basic worldwide health issue; the interleukin-10 is an anti-inflammatory mediator that has a role in normal kidney function and in the progression of chronic renal failure. This study aims to measure the serum level of anti-inflammatory cytokines (IL-10), and evaluate its role in the progression of chronic kidney disease (CRD). The study comprised 66 patients divided into group 1 (22 subjects with CKD) and 2 (22 CRD patients with Diabetic mellitus name as DM-CRD), and group 3 (22 patients with Diabetic mellitus DM only without CRD). In addition to 22 consider as healthy people as control. The serum levels of IL-10 were determined by using ELISA assay. The results demonstrated a significant increase in the serum means levels of IL-10 in all patient groups (CKD, DM-CKD, DM) in comparison with healthy control, while there was nonsignificant difference in its mean serum levels among all patient groups. It was concluded that male and aging are predisposing factors to chronic renal disease, and elevated levels of IL-10 in patients with CKD and diabetes reflect the potential role of IL-10 in the progression of diabetic nephropathy patients to chronic renal disease
Received: 2024-06-03
Revised:2024-06-28
Accepted: 2024-07-01
References
W. Wei, Y. Zhao, Y. Zhang, H. Jin, and S.Shou. "The role of IL-10 in kidney disease". Int Immunopharmacol.Vol.2022,No.108,pp.108917, 2022 . [2] S. A Fathy, M. R Mohamed,., M. A Ali,.,A. E. El-Helaly, , and A. T. Alattar. "Influence of IL-6, IL-10, IFN-γ and TNF-α genetic variants on susceptibility to diabetic kidney disease in type 2 diabetes mellitus atients". Biomarkers,Vol. 24,No.1,pp. 43-55, 2019.
T Petreski,., N Piko, R Ekart., R Hojs,., and S.Bevc,."Review on inflammation markers in chronic kidney disease". Biomedicines,Vol. 9,No.2,, pp.182, 2021.
W. E Ip,., N. Hoshi , D. S Shouval., S.Snapper , and R.Medzhitov. "Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages". Science, Vol. 356,No., 6337,PP. 513-519, 2017 .
I.Sinuani, , I.Beberashvili, Z.Averbukh, , and J.Sandbank, "Role of IL-10 in the progression of kidney disease". World journal of transplantation, Vol. 3,No.4, pp. 91, 2013.
M. I Yilmaz., Y.Solak, , M.Saglam, , T.Cayci, , C.Acikel , H. U Unal,., et al. "The relationship between IL-10 levels and cardiovascular events in patients with CKD". Clinical Journal of the American Society of Nephrology. Vol. 9, No.7, pp. 1207-1216, 2014 .
C.Gao, , F Peng,., X Xie,., and L. Peng, ." The Relationship Between Blood Interleukin-10 and Cardiovascular Mortality and All-Cause Mortality After Kidney Transplantation". Risk Management and Healthcare Policy,pp.1481-1489,2021 .
H.M Dekheel, HM Mousa. "The role of anti-Dsdna antibody in progression of chronic renal failure in Iraqi patients Inthi-Qar province". Jundishapur Journal of Microbiology, Vol. 15,No.2, pp.608-615, 2022.
A. A. Shalash. "Case-Control Study of Risk Factors for End-Stage Renal Failure among Patients on Hemodialysis in Alkindy Hospital in Baghdad City". people, Vol.10,No. 11,2020 .
B.M Muhammad-Baqir , EN Hameed, RH Shareef, and MH Ahmed." Impact of erythropoietin on anemia in end-stage renal disease patients on hemodialysis". Medical Journal of Babylon.Vol.20No.3, pp.558-563,2023.
J.V Zhao, and CM Schooling. "The role of testosterone in chronic kidney disease and kidney function in men and women: a bi-directional Mendelian randomization study in the UK Bioban"k. BMC medicine. Vol.18,pp.1-10, 2020.
N. Halbesma, A.H. Brantsma, SJ Bakker, Jansen DF, RP Stolk, D. De Zeeuw, et al. "Gender differences in predictors of the decline of renal function in the general population". Kidney international.Vol.74, No..4,pp.505-512, 2008.
S. H. Azeez, and S. N. Darogha "The impact of IL-10 gene polymorphism 1082A/G (rs1800896) on increased IL-10 secretion in patients with chronic kidney disease in the Kurdistan region of Iraq". Investigación Clínica, Vol.60,No.1,pp. 29-37,2019.
M. M. S. Saleh and Z. A Ahmed, ." Immunological Profile In Different Groups Of End Stage Renal Disease". Al-Kufa University Journal for Biology, Vol.8,No. 3, pp.7-15,2016 .
J. Myśliwska, K. Zorena, E. Semetkowska-Jurkiewicz, D. Rachoń, H. Suchanek, A. Myśliwski "High levels of circulating interleukin-10 in diabetic nephropathy patients". European cytokine network, Vol.16,No.2, pp. 117-122,2005
A. A. G Shyeaa, M. A. D. Saleh, and , N. K Tektook. "Immunological role of TLR-7, IL-17A and IL-10 In a Sample of Iraqi Chronic Renal Failure Patients". Medico-legal Update, Vol.20,No.,1,.2020.
R. Kartika, D Purnamasari, S. Pradipta,., R. A Larasati and H.Wibowo." Impact of low interferon-γ and IL-10 levels on TNF-α and IL-6 production by PHA-induced PBMCs in type 2 diabetes mellitus". Journal of Inflammation Research, pp.187-193,2020 .
A. S. Lateef, M. R Alkubaisi , I K. AL-Hitti ,K. F.AL-Rawi , Y. T. Freah ,A. J.Khalaf, et al. “Evaluation of Serum Lipid Profile and Renal Function Levels in Iraqi Patients with Chronic Kidney Disease (CKD)”, Iraqi Journal of Science, vol. 65, no. 4, pp. 1877–1885, Apr. 2024.
N. Singhal, D. R. D. Mathur, D. A. K. Bhargava, and D. D. Gupta, “Comparative study of renal function test and thyroid hormone in chronic kidney disease,” Int. J. Med. Res. Rev., vol. 8, no. 6, pp. 427–431, 2020.
A. A. Khesbak, “The Effect of Some Biochemical and Physiological Parameters in Iraqi Patients with Renal Failure,” J. Biol. Agric. Healthc., vol. 10, no. 14, pp. 2018–2021, 2020.
H. F. Hassen, M. Q. D. Al-Lami, and A. J. H. Al-Saedi, “Evaluation some Biochemical Levels in Patients undergoing Hemodialysis in Baghdad Governorate,” J. Adv. Lab. Res. Biol., vol. 9, no. 2, pp. 50–57, 2018
Downloads
Published
License
Copyright (c) 2024 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
